Francesca Langone

844 total citations
13 papers, 496 citations indexed

About

Francesca Langone is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Francesca Langone has authored 13 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Francesca Langone's work include Cancer Immunotherapy and Biomarkers (4 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Francesca Langone is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Virus-based gene therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Francesca Langone collaborates with scholars based in Italy, United States and Switzerland. Francesca Langone's co-authors include Gianni Cesareni, Luisa Castagnoli, Elisa Scarselli, Elena Santonico, Anna Morena D’Alise, Alberto Calderone, Andrea Cerquone Perpetuini, Gabriella Cotugno, Guido Leoni and Daniela Posca and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Francesca Langone

13 papers receiving 488 citations

Peers

Countries citing papers authored by Francesca Langone

Since Specialization

Citations

This map shows the geographic impact of Francesca Langone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Langone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Langone more than expected).

Fields of papers citing papers by Francesca Langone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Langone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Langone. The network helps show where Francesca Langone may publish in the future.

Co-authorship network of co-authors of Francesca Langone

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Langone. A scholar is included among the top collaborators of Francesca Langone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Langone. Francesca Langone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	First clinical and immunogenicity results including all subjects enrolled in a phase I study of Nous-209, an off-the-shelf immunotherapy, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability (dMMR/MSI). 2022 ·Journal of Clinical Oncology ·Marwan Fakih, Dung T. Le, Katrina S. Pedersen, Anthony F. Shields, Manish A. Shah, Sarbajit Mukherjee, (unknown), (unknown), Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno, Francesca Langone, Elisa Scarselli, Michael J. Overman	6
2	1004P Initial results from a phase I study of Nous-209, an off-the-shelf viral vectored immunotherapy encoding 209 shared frame shift peptide neoantigens, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability 2021 ·Annals of Oncology ·Michael J. Overman, Guido Leoni, Anna Morena D’Alise, Gabriella Cotugno, Francesca Langone, Stefania Capone, (unknown), Marwan Fakih, Dung T. Le, Anthony F. Shields, Katrina S. Pedersen, Manish A. Shah, Sarbajit Mukherjee, (unknown), (unknown), Elisa Scarselli	3
3	Maximizing cancer therapy via complementary mechanisms of immune activation: PD-1 blockade, neoantigen vaccination, and Tregs depletion 2021 ·Journal for ImmunoTherapy of Cancer ·Anna Morena D’Alise, Guido Leoni, (unknown), Francesca Langone, Linda Nocchi, (unknown), Elisa Micarelli, Gabriella Cotugno, Fulvia Troise, (unknown), Rosa Vitale, (unknown), (unknown), Rosa Bartolomeo, Deborah H. Charych, Armin Lahm, Jonathan Zalevsky, Alfredo Nicosia, Elisa Scarselli	8
4	410 Phase I interim study results of Nous-209, an off-the-shelf immunotherapy, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability (dMMR/MSI) 2021 ·Regular and Young Investigator Award Abstracts ·Michael J. Overman, Marwan Fakih, Dung T. Le, Anthony F. Shields, Katrina S. Pedersen, Manish A. Shah, Sarbajit Mukherjee, (unknown), Guido Leoni, Anna Morena D’Alise, Gabriella Cotugno, Francesca Langone, Stefania Capone, (unknown), Elisa Scarselli, (unknown)	12
5	VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens’ Prediction 2021 ·Vaccines ·Guido Leoni, Anna Morena D’Alise, (unknown), Elisa Micarelli, (unknown), (unknown), Francesca Langone, Linda Nocchi, Gabriella Cotugno, Rosa Bartolomeo, Giuseppina Colonna Romano, (unknown), Fulvia Troise, Alfredo Nicosia, Armin Lahm, Elisa Scarselli	11
6	Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment 2020 ·Molecular Therapy — Oncolytics ·(unknown), Gabriella Cotugno, (unknown), (unknown), Linda Nocchi, Francesca Langone, (unknown), Emanuele Sasso, (unknown), (unknown), Chiara Gentile, Nicola Zambrano, Gabriella Campadelli‐Fiume, Alfredo Nicosia, Elisa Scarselli, Anna Morena D’Alise	27
7	Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of Herpes Simplex Oncolytic Virus 2020 ·Cancers ·(unknown), (unknown), Chiara Gentile, Anna Morena D’Alise, (unknown), Francesca Langone, Guido Leoni, Gabriella Cotugno, (unknown), Alfredo Nicosia, Elisa Scarselli, Massimo Mallardo, Emanuele Sasso, Nicola Zambrano	33
8	Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade 2019 ·Nature Communications ·Anna Morena D’Alise, Guido Leoni, Gabriella Cotugno, Fulvia Troise, Francesca Langone, (unknown), (unknown), Lidia Avalle, Rosa Vitale, (unknown), (unknown), (unknown), (unknown), Valeria Poli, Armin Lahm, Maria Teresa Catanese, Antonella Folgori, Stefano Colloca, Alfredo Nicosia, Elisa Scarselli	76
9	Osteogenic differentiation of skeletal muscle progenitor cells is activated by the DNA damage response 2019 ·Scientific Reports ·Marco Rosina, Francesca Langone, Giulio Giuliani, Andrea Cerquone Perpetuini, Alessio Reggio, Alberto Calderone, Claudia Fuoco, Luisa Castagnoli, Cesare Gargioli, Gianni Cesareni	12
10	SIGNOR: a database of causal relationships between biological entities 2015 ·Nucleic Acids Research ·Livia Perfetto, Leonardo Briganti, Alberto Calderone, Andrea Cerquone Perpetuini, Marta Iannuccelli, Francesca Langone, Luana Licata, Milica Marinkovic, Anna Mattioni, Theodora Pavlidou, Daniele Peluso, Lucia Lisa Petrilli, S Pirro, Daniela Posca, Elena Santonico, Alessandra Silvestri, Filomena Spada, Luisa Castagnoli, Gianni Cesareni	167
11	The adapter protein CD2AP binds to p53 protein in the cytoplasm and can discriminate its polymorphic variants P72R 2014 ·The Journal of Biochemistry ·Simona Panni, Stefano Salvioli, Elena Santonico, Francesca Langone, (unknown), Serena Altilia, Claudio Franceschi, Gianni Cesareni, Luisa Castagnoli	8
12	Metformin Protects Skeletal Muscle from Cardiotoxin Induced Degeneration 2014 ·PLoS ONE ·Francesca Langone, Stefano Cannata, Claudia Fuoco, Daniele Lettieri‐Barbato, Stefano Testa, Aurelio Pio Nardozza, Maria Rosa Ciriolo, Luisa Castagnoli, Cesare Gargioli, Gianni Cesareni	46
13	The SH2 Domain Interaction Landscape 2013 ·Cell Reports ·Michele Tinti, Lars Kiemer, Stefano Costa, Martin L. Miller, Francesca Sacco, Jesper V. Olsen, Martina Carducci, Serena Paoluzi, Francesca Langone, Christopher T. Workman, Nikolaj Blom, Kazuya Machida, Christopher M. Thompson, Mike Schutkowski, Søren Brunak, Matthias Mann, Bruce J. Mayer, Luisa Castagnoli, Gianni Cesareni	87

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact